Prehydration not needed before contrast CT of kidneys
Prehydrating patients who have chronic kidney disease before they undergo a...Read more on AuntMinnie.comRelated Reading: Experts reaffirm safety of contrast use for kidney CT Could patient history help predict CT contrast reactions? Oral contrast not needed to spot kids' appendicitis on CT Contrast use doesn't change acute kidney injury rate CT contrast not tied to poor outcomes, even in at-risk patientsComments: 2/18/2020 6:19:39 PMChris Woodhouse You guys are driving me crazy!  Just when I get the clinic settled into the practice of pushing clear fluids before any contrast study, you tell me it doesn't ...
Source: AuntMinnie.com Headlines - February 19, 2020 Category: Radiology Source Type: news

Roche provides an update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer
            Basel, 24 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMvigor010 study evaluating Tecentriq® (atezolizumab) as an adjuvant (after surgery) monotherapy treatment did not meet its primary endpoint of disease-free survival (DFS) compared to observation in people with muscle-invasiv e urothelial cancer (MIUC). Safety for Tecentriq appeared consistent with the known safety profile of the medicine, and no new safety signals were identified.“Reducing the risk that muscle-invasive urothelial cancer will recur after surgery is ve...
Source: Roche Investor Update - January 24, 2020 Category: Pharmaceuticals Source Type: news

Roche provides an update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer
Basel, 24 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMvigor010 study evaluating Tecentriq® (atezolizumab) as an adjuvant (after surgery) monotherapy treatment did not meet its primary endpoint of disease-free survival (DFS) compared to observation in people with muscle-invasiv e urothelial cancer (MIUC). Safety for Tecentriq appeared consistent with the known safety profile of the medicine, and no new safety signals were identified.“Reducing the risk that muscle-invasive urothelial cancer will recur after surgery is very difficult, and we are disappointed that we w...
Source: Roche Media News - January 24, 2020 Category: Pharmaceuticals Source Type: news

MIT Researchers Develop Treatment That Could Make Passing Kidney Stones Less Painful
CAMBRIDGE (CBS) – A new treatment could help ease the passage of kidney stones, according to researchers at MIT and Massachusetts General Hospital. Scientists said this week that muscle relaxants can reduce the contractions that cause pain when passing the stones. About 1 in 10 people will have the painful experience of kidney stones. They cause more than 500,000 emergency room visits in the United States every year. But local researchers think they’ve made a discovery that can help. They say delivering a combination of two muscle relaxants directly to the ureter, the tube that connects the kidneys and bladder,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 3, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Cambridge News Kidney Stones MIT Source Type: news

An end to the pain of kidney stones? New drug combination allows the stones to pass smoothly
Researchers at MIT have identified a combination of muscle-relaxing drugs that, when administered to the ureter, eliminated pain in pigs with kidney stones. It would be the first new treatment in 40 years. (Source: the Mail online | Health)
Source: the Mail online | Health - December 2, 2019 Category: Consumer Health News Source Type: news

Medical News Today: What to know about passing a kidney stone
Kidney stones are an accumulation of chemicals or minerals that form in the kidney or ureter. They can cause pain and discomfort. Read on to find out how long it takes to pass a kidney stone and how to speed up the process. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 24, 2019 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Renal Anomaly on Fetal Scan May Up Risk for Admission for Child
THURSDAY, Aug. 15, 2019 -- Renal pelvis dilatation (RPD) at the fetal anomaly scan (FAS) and persistent dilatation in later pregnancy or postpartum is associated with an increased risk for hospital admission in early childhood, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 15, 2019 Category: Pharmaceuticals Source Type: news

Merit Stays the Course with Brightwater Acquisition
Merit Medical Systems said it has acquired Brightwater Medical for a $35 million upfront payment and potential earn-out payments of up to $15 million based on receipt of CE mark approval and achievement of future sales targets. Brightwater's primary product is the ConvertX, which is a single device used to replace a series of devices and procedures used to treat severe obstructions of the ureter. The system is designed to be implanted once and converted from a nephroureteral catheter to a nephroureteral stent without requiring sedation or local anesthesia. The device is FDA cleared but does not yet have CE mark approval in...
Source: MDDI - June 17, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Radiological Case: Extraperitoneal Herniation of the Ureter Radiological Case: Extraperitoneal Herniation of the Ureter
What did CT scan reveal about the unusual cause of this patient's one-year history of abdominal bloating and distention?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 10, 2019 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news

Localized Ureteral Amyloidosis Mimicking Urothelial Carcinoma Localized Ureteral Amyloidosis Mimicking Urothelial Carcinoma
How was the unusual origin of this patient's left-sided flank pain determined?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 12, 2018 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news

Black cumin prevents kidney damage
(Natural News) The extract of black cumin (Nigella sativa) can help treat kidney damage induced by unilateral ureteral obstruction (UUO). This was what a study, published in the journal Phytochemical Research, found. The researchers administered an intraperitoneal injection of losartan (15 mg/kg), captopril (30 mg/kg), 200 mg/kg of N. sativa extract (NS), and 400 mg/kg NS... (Source: NaturalNews.com)
Source: NaturalNews.com - October 26, 2018 Category: Consumer Health News Source Type: news

Radiological Case: Spontaneous Ureteral Injury Radiological Case: Spontaneous Ureteral Injury
What was the cause of this woman's worsening abdominal pain, tachycardia, and mild hypotension following a reportedly uncomplicated vaginal delivery?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 31, 2018 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news

Bilateral distal ureteral transection in the setting of blunt trauma - Raygor D, Cunningham J, Costa J, Crandall M, Skarupa D.
A 69-year-old obese man was involved in a high-speed head-on motor vehicle collision. He was tachycardic and normotensive on arrival. He subsequently developed hemodynamic instability requiring blood transfusion. On examination he had bilateral pneumothora... (Source: SafetyLit)
Source: SafetyLit - July 24, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Medical News Today: Lithotripsy for stones: What to expect
Lithotripsy is a procedure that uses shock waves or lasers to break down stones in the kidneys, bladder, or ureter. In this article, learn about how the procedure works, the success rate, how to prepare, and what to expect during recovery. We also cover the possible risks and side effects. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 4, 2018 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Alpha-blockers Do Not Promote Passage of Urinary Stones Alpha-blockers Do Not Promote Passage of Urinary Stones
A new study adds to evidence that alpha-blockers do not expedite the passage of ureteral stones in patients who present with renal colic compared with placebo, although stone size may matter.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 19, 2018 Category: Consumer Health News Tags: Urology News Source Type: news

Low Risk for Ureteral Stricture From Cervical Ca Brachytherapy Low Risk for Ureteral Stricture From Cervical Ca Brachytherapy
Neither intracavitary nor interstitial brachytherapy increases the risk for ureteral stricture in locally advanced cervical cancer, except in the setting of hydronephrosis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Hydronephrosis Ups Risk of Deadly Complication in Cervical Ca (CME/CE)
(MedPage Today) -- Pronounced increase in risk for severe ureteral stricture post-brachytherapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 24, 2018 Category: Hematology Source Type: news

Brachytherapy for cervical cancer does not increase the risk of ureteral stricture
(European Society for Radiotherapy and Oncology (ESTRO)) New research presented at the ESTRO 37 conference from two large international trials, shows that intracavitary and interstitial brachytherapy is safe and does not increase the risk of ureteral stricture in cervical cancer patients. Until now, there have been concerns that brachytherapy might increase the risk of this serious, sometimes life-threatening complication, although the treatment itself is associated with better survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 20, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: What does having nitrites in urine mean?
Nitrites appear in the urine when a person has a bacterial infection in their bladder, ureter, or kidneys. Who should be tested for nitrites, and how are they formed? Learn more here. We also describe symptoms of urinary tract and kidney infections, as well as their treatments and possible complications. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 30, 2018 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Tamsulosin Helps With Expulsion Of Larger Distal Ureteral Stones Tamsulosin Helps With Expulsion Of Larger Distal Ureteral Stones
Tamsulosin facilitates the passage of larger distal ureteral stones and relieves renal colic, researchers from China report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 30, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

More Than $500K in Prizes on the Line for Four Startups
It’s down to just four companies in the 2017 MedTech Innovator $500K Competition, whittled down from a field of almost 600 companies. The finalists, which emerged from the 20-company MedTech Innovator Accelerator, will vie for the top prize next week. Representatives from each company will pitch to an audience and judging panel during a session at The MedTech Conference in San Jose, CA on September 26. The panel of judges, which includes leaders from Johnson & Johnson, Baxter Ventures, Becton Dickinson, and Kaiser Permanente Ventures, will ask questions before the session audience casts their votes. The medical t...
Source: MDDI - September 22, 2017 Category: Medical Devices Authors: Marie Thibault Tags: Medical Device Business Source Type: news

Kidney Cancer Renal Pelvis and Ureter
Kidney Cancer: Renal Pelvis and Ureter (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 22, 2017 Category: General Medicine Source Type: news

Cogentix Medical buys UK-based Genesis Medical
Cogentix Medical (NSDQ:CGNT) said today it acquired London-based Genesis Medical for an undisclosed amount. Genesis Medical produces, sells and markets urology products in the U.K. and operated as the exclusive regional distributor for Cogentix’s PrimeSight endoscopy systems. Cogentix said it purchased all tangible assets of Genesis, and will pay up to an additional $671,560 (GBP £515,000) based on revenue milestones through March 2019. “The purchase of Genesis Medical is our second business development transaction this month and follows our announcement last week of an Endo-Urology product line laun...
Source: Mass Device - July 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Urology Cogentix Medical Source Type: news

Cogentix inks deal with Promepla to launch endo-urology devices in US
Cogentix Medical (NSDQ:CGNT) said today it inked a deal with Monaco-based medical device maker Promepla to launch an endo-urology product line within the US. Minneapolis, Minn.-based Cogentix said the slated-to-launch product line includes a full suite of endourological devices including ureteral access sheaths, gravity irrigation lines and nitinol guide wires. “The launch of our endo-urology product line in the U.S. is one of the first steps in executing our business development strategy. Our primary focus for business development has been to add products that can immediately leverage the relationships our U.S....
Source: Mass Device - July 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Urology Cogentix Medical Promepla Source Type: news

Renal Nerves and Blood Pressure
Role of Calcitonin gene-related peptide (CGRP) CGRP is a potent vasodilator so it is not surprising ourCGRP Antibody was used in this study. Cust ódio AH, de Lima MC, Vaccari B, Boer PA, Gontijo JAR (2017)Renal sodium handling and blood pressure changes in gestational protein-restricted offspring: Role of renal nerves and ganglia neurokinin expression. PLoS ONE 12(6): e0179499. https://doi.org/10.1371/journal.pone.0179499Figure. Comparative expression of SP and CGRP in the renal pelvis of 16-week-old rats. The pictures show a normal distribution of these neurokinins in NP (A and D). In LP offspring, no difference wa...
Source: Neuromics - July 5, 2017 Category: Neuroscience Tags: Blood Pressure CGRP antibody sodium channels Source Type: news

Ureteroscopy, Lithotripsy Have Different Risk-benefit Profile for Upper Ureteral Stones Ureteroscopy, Lithotripsy Have Different Risk-benefit Profile for Upper Ureteral Stones
Ureteroscopy and shock-wave lithotripsy have different relative benefits and harms in patients with upper ureteral stones, according to a new systematic review.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - May 11, 2017 Category: Urology & Nephrology Tags: Urology News Source Type: news

Carrying Savanna through her journey with cloacal malformation
When two-year-old Savanna Bluford enters Boston Children’s Colorectal and Pelvic Malformation Center, she quickly gravitates toward the waiting room’s interactive light board. Sporting pigtails, sparkly sneakers and an angelic smile, the playful toddler’s attention quickly turns to her doctor — the Center’s Co-Director Dr. Belinda Dickie. The two light up with smiles and exchange hugs as if old friends — and that, they are. Savanna was born in South Carolina with a rare and complex birth defect affecting the gastrointestinal, urological and reproductive systems. The condition, called cov...
Source: Thrive, Children's Hospital Boston - May 3, 2017 Category: Pediatrics Authors: Maureen McCarthy Tags: Diseases & Conditions Our Patients’ Stories Belinda Dickie cloacal malformation Colorectal and Pelvic Malformation Center Leonel Rodriguez Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 12, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. GE, Hartford Healthcare ink 7-year value based care partnership GE Healthcare said today it is collaborating with Hartford HealthCare to launch a series of value-based healthcare projects over the next 7 years. The companies sa...
Source: Mass Device - April 12, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Cook Medical recalls select Bush ureteral illuminating caths
Cook Medical this week released information on a select voluntary recall of its Bush DL and Bush SL ureteral illuminating catheter sets over issues with overheating. The Bloomington, Ind.-based company said it has received an increased number of reports of the proximal black component that connects to the distal transparent component overheating and melting, which could potentially cause burns. Cook Medical clarified that it has received no reports of any overheating along the transparent component of the catheter which comes into contact with the patients’ urethra, bladder and ureter. The recall affects Bu...
Source: Mass Device - April 12, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Recalls Urology Cook Medical Source Type: news

From Interventional Radiologist to Medtech CEO: Interview with Dr. Bob Smouse, Founder of BrightWater Medical
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! Dr. Bob Smouse has over 20 years of experience in interventional radiology, endovascular surgery and clinical research. In addition to acting as CEO and CMO of BrightWater Medical and teaching at the University of Illinois College of Medicine, he provides interventional medical services to local hospitals through Central Illinois Radiology Associates. Dr. Smouse is a medical consultant and scientific advisory board mem...
Source: Mass Device - February 10, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Blog medsider Smouse Source Type: news

DeviceTalks Q & A: Verb Surgical CEO Scott Huennekens
Few CEOs have been given the mandate Scott Huennekens was charged with as employee No. 1 at Verb Surgical, the robotics spinout backed by Google (NSDQ:GOOG) and Johnson & Johnson (NYSE:JNJ): Go forth and change the world. “Don’t worry about capital, don’t worry about funding,” Huennekens told MassDevice.com publisher Brian Johnson recently. “Just go out and change the world.” Many CEOs might find that daunting. Then again, most CEOs don’t have a $400 million war chest and the backing of 2 of the world’s most innovative companies. And, as...
Source: Mass Device - December 21, 2016 Category: Medical Equipment Authors: MassDevice Tags: DeviceTalks Q&A Robot-Assisted Surgery Wall Street Beat Alphabet Google Inc. Johnson & Johnson Medtronic Verb Surgical Volcano Corp. Source Type: news

Convertible Stent for Ureteral Obstruction Clears FDA Convertible Stent for Ureteral Obstruction Clears FDA
The ConvertX nephroureteral stent system converts from a catheter to a stent in a short office procedure, eliminating the need for a second interventional procedure.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 5, 2016 Category: Consumer Health News Tags: Urology News Alert Source Type: news

MassDevice.com +5 | The top 5 medtech stories for December 5, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA clears BrightWater Medical’s ConvertX nephroureteral stent Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating ...
Source: Mass Device - December 5, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

FDA clears BrightWater Medical ’ s ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating ureteral obstructions. The ConvertX System is designed as a single device intended to replace a series of devices and procedures used to treat severe obstructions of the ureter. Traditional interventions require an implanted nephrostomy catheter to externally drain urine and a second procedure to implant a nephroureteral stent to circumvent blockage. Mountain View, Calif.-based BrightWater’s system is designed to be implanted once and convert from a ne...
Source: Mass Device - December 3, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Urology BrightWater Medical Source Type: news

Dx: Prostatic Mass
Upon seeing the images on the screen, you notice a tinge of red in your resident’s cheeks as she begins her spiel about the need to perform a prostate exam as part of the work up today. She eloquently explains to the patient that the ultrasound results and his symptoms are concerning for a prostatic mass that is eroding into the base of his urinary bladder (Image 3). On the transverse view of the bladder a hyperechoic mass can be seen along the posterior wall of the bladder. In the longitudinal view, you can see the hypoechoic lumen of the mass originating from the prostate to the lower left of the bladder wall. Your...
Source: EPMonthly.com - December 2, 2016 Category: Emergency Medicine Authors: Logan Plaster Tags: Uncategorized Source Type: news

Meta-Analysis: Alpha Blockers Associated with Passage of Ureteral Stones (FREE)
By Kelly Young Edited by Andr é Sofair, MD, MPH, and William E. Chavey, MD, MS Alpha blockers are associated with high rates of ureteral stone passage, a meta-analysis in The BMJ finds.Researchers analyzed … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 2, 2016 Category: Primary Care Source Type: news

Sodium Fluorescein, 10% Dextrose Show Ureteral Patency Best Sodium Fluorescein, 10% Dextrose Show Ureteral Patency Best
Both solutions showed urine jets more clearly than saline or oral phenazopyridine with no increase in operative time or morbidity, data from a randomized trial show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Your NEJM Group Today: Scaling Patient Engagement Initiatives, Tamsulosin for Ureteral Stones, Ohio FM/IM Opportunities (FREE)
By the Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Catalyst: When … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 20, 2016 Category: Primary Care Source Type: news

Medical Expulsive Therapy Might Benefit Patients With Larger Ureteral Stones, Group Says Medical Expulsive Therapy Might Benefit Patients With Larger Ureteral Stones, Group Says
Medical expulsive therapy (MET) with alpha-blockers might enhance the passage of distal ureteral stones larger than 5 mm, according to a position statement from the European Association of Urology.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - September 6, 2016 Category: Urology & Nephrology Tags: Nephrology News Source Type: news

Texas Medical Centers adds 11 medtech startups to incubator
The Texas Medical Center Innovation Institute on Wednesday announced the addition of 11 startups specifically focused on medical devices, a 1st for the incubator, as part of its TMCx program. As part of the program, for 15 weeks the startups will engage and collaborate with “top industry experts” to move their medical devices from concept to commercialization, the group said. Startup companies will also meet with stakeholders at the 56 member institutions within the Texas Medical Center. “Very few accelerators have a robust program devoted to medical device startups, so we are filling a huge gap in the li...
Source: Mass Device - August 12, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Research & Development Texas Medical Center Innovation Institute Source Type: news

Boston Scientific updates warnings for pelvic mesh products
Boston Scientific (NYSE:BSX) recently updated the directions for use and warnings for its pelvic mesh products, classifying the meshes as permanent implants and warning of complications related to removals. The Marlborough, Mass.-based company added new precautions to the directions for the meshes, warning that that “regardless of the route of delivery,” the meshes have been associated with “erosion” which may require surgical removal. “Complete removal of mesh may not be possible and additional surgeries may not always fully correct the complications,” the company wrote in its...
Source: Mass Device - June 14, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Surgical Urology Women's Health Boston Scientific Source Type: news

BrightWater raises $5.2m in Series A to support ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it closed a $5.2 million Series A round of financing to support its ConvertX Nephroureteral stent system designed for treating severe ureteral obstructions from development to regulatory filing. The ConvertX System is designed as a single device intended to replace a series of devices and procedures used to treat severe obstructions of the ureter. Traditional interventions require an implanted nephrostomy catheter to externally drain urine and a second procedure to implant a nephroureteral stent to circumvent blockage. BrightWater’s system is designed to ...
Source: Mass Device - May 24, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Urology BrightWater Medical Source Type: news

FDA grants Roche’s cancer immunotherapy Tecentriq (atezolizumab) accelerated approval for people with a specific type of advanced bladder cancer
Roche today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Tecentriq® (atezolizumab) for the treatment of people with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-based chemotherapy, or whose disease has worsened within 12 months of receiving platinum-based chemotherapy before surgery (neoadjuvant) or after surgery (adjuvant). Urothelial carcinoma accounts for 90% of all bladder cancers and can also be found in the renal pelvis, ureter and urethra. (Source: Roche Media News)
Source: Roche Media News - May 19, 2016 Category: Pharmaceuticals Source Type: news

More urinary tract stones are being treated with surgery
Researchers who analyzed recent trends related to urinary tract stones in the UK found a sustained and high prevalence of the condition, with an increased trend to treat patients with surgery. The number of upper urinary tract stone episodes in hospitals increased from 83,050 in 2009-2010 to 86,742 in 2014-2015. The use of non-invasive shock wave lithotripsy remained stable over this time; however, surgical intervention for stones in the ureter or kidney rose nearly 50% from 12,062 to 18,055 cases in the 5-year study period. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 12, 2016 Category: Science Source Type: news

New Device Aims to Ease Burden of Treating Ureteral Blockages
(Source: MDDI)
Source: MDDI - April 25, 2016 Category: Medical Equipment Authors: Arundhati Parmar Tags: Stents Source Type: news

Study shows that Wnt secretion preventing drugs may reduce renal fibrosis
For media queries, please contact: Ms Dharshini Subbiah                                                                  Duke-NUS Medical School Email: dharshini.subbiah@duke-nus.edu.sg Mobile: (65) 9616-7532 Renal fibrosis or the scarring of kidneys, following an injury, reduces their function and can cause kidney disease to progressively worsen. In a recent study, published in Kidney International, researchers from Duke-NUS Medical School (Duke-NUS) in Singap...
Source: DukeHealth.org: Duke Health Features - March 30, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

Boston Scientific releases ureteral stent tracker app
Boston Scientific (NYSE:BSX) has launched a new app designed to help urologists track ureteral stents implanted in patients with kidney stones. The app was developed as a joint operation between the Marlborough, Mass.-based medical device company and digital healthcare tool developer Visible Health, according to the company’s website. The tracker is designed to address issues with retained ureteral stents by making them more visible to both the care team and the patient themselves, Visible Health said. Boston Scientific said that 13 out of 100 ureteral stents will be forgotten after implantation, and 10 of ...
Source: Mass Device - March 3, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Patient Monitoring Software / IT Urology Boston Scientific Source Type: news

Boston Scientific, app developer launch Ureteral Stent Tracker app
Boston Scientific has launched a new app, called the Ureteral Stent Tracker, that helps urologists and their staff keep tabs on ureteral stents implanted in patients with kidney stones. The app was developed in partnership with health app developer Visible Health. (Source: mobihealthnews)
Source: mobihealthnews - March 2, 2016 Category: Information Technology Source Type: news

Kidney stones are on the rise
This study and past research have not been able to determine the reason kidney stones seem to be on the rise. The rising rate of obesity may be playing a role. Another possibility is climate change, as warmer temperatures encourage dehydration. The fact is, no one knows for sure. What’s a person to do? If you have symptoms of kidney stones, see your doctor or report directly to an emergency room. The most common symptoms are waves of pain in the back or lower abdomen, pain with urination, or blood in the urine. If you’ve already been diagnosed with a kidney stone, it’s important to figure out why it happe...
Source: New Harvard Health Information - February 12, 2016 Category: Consumer Health News Authors: Robert Shmerling, M.D. Tags: Kidney and urinary tract Source Type: news

Finding comfort and hydronephrosis care close to home
AJ Arria was diagnosed and treated at Boston Children’s for hydronephrosis – a urological condition where urine backs up into the kidneys. Every child has a favorite thing. Some find comfort in the softness of a blanket, while others prefer snuggling a stuffed animal. Whatever the soothing item is, every parent cringes at the thought of misplacing it. Michelle Arria remembers the day her 18-month-old son Anthony James (AJ) visited Boston Children’s Hospital for testing. It was the day his favorite blanket was lost. “Testing was about to begin, and I went to get AJ’s blanket, and...
Source: Thrive, Children's Hospital Boston - January 27, 2016 Category: Pediatrics Authors: Maureen McCarthy Tags: Diseases & Conditions Our Patients’ Stories Boston Children's at Peabody Hydronephrosis minimally invasive surgery Richard Yu urology Source Type: news